Last Updated on March 10, 2024 by The Health Master
Indian Pharma Industry
Indian Pharma Industry: The U.S. drug regulator is gearing up to intensify inspections at Indian drug manufacturing units in 2024, expressing concerns over the quality of drugs.
In a recent conversation with Reuters, a top executive from the U. S. Food and Drug Administration (USFDA) shed light on this development.
USFDA’s Plans for Increased Inspections
2023 witnessed a resurgence in unannounced inspections by the USFDA in India, totaling over 200.
Sarah McMullen, USFDA Country Director (India), affirmed the agency’s commitment to further increasing inspections and requesting additional drug investigators to be stationed in the country.
Insights from 2023 Inspections
The USFDA’s vigilance in 2023 marked a departure from the lull in unannounced inspections during the pandemic.
This proactive approach underscores the significance of ensuring drug quality and safety.
Sarah McMullen’s Perspective on Inspections
McMullen emphasized the agency’s dedication to raising inspection numbers, highlighting the pivotal role these inspections play in maintaining pharmaceutical standards.
Her remarks signal the urgency of addressing potential gaps in the current monitoring system.
India Pharma Industry Growth
India pharma industry, valued at $42 billion, is striving to expand its global footprint.
With the government actively encouraging adherence to good manufacturing practices, the industry aims to meet international standards.
Addressing Concerns Over Drug Quality
Growing global concerns over the quality of drugs, especially those manufactured in India, have prompted regulatory action.
The USFDA’s focus on inspections aligns with the need to reassure consumers about the safety and efficacy of pharmaceutical products.
The Significance of the US Market
The United States constitutes 30% of India’s total pharmaceutical product exports.
The USFDA’s increased scrutiny has implications not only for India’s domestic market but also for its crucial role in the global pharmaceutical supply chain.
The Need for Investment in Automation
McMullen highlighted the necessity for the Indian pharmaceutical industry to invest in automation to enhance compliance.
As the industry grows, adopting advanced technologies becomes paramount to ensure consistency and quality.
Investments in the Pharmaceutical Industry
While the Indian government is actively investing in the pharmaceutical sector, there’s a call for simultaneous investment in strengthening the resources of the country’s drug regulatory body.
This dual approach can foster sustainable growth and adherence to global standards.
Strengthening the Drug Regulatory Body
In addition to industry investments, McMullen stressed the need for enhancing the resources of India’s drug regulatory body.
Strengthening this oversight is crucial for effective monitoring and regulation, aligning with the industry’s rapid expansion.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
CDSCO approval granted for Plazomicin injection in India
Tamil Nadu: The Restructuring of (DCA) Drugs Control Administration
Beyond Paperwork: CDSCO’s Bold Move to Online PSUR Submissions
A Crucial Amendment: Revolutionizing Surrogacy Rules
Gujarat FDCA seized Fake Drugs worth Rs. 1.75 crore
Regulator’s Guide: Mastering the Art of Effective Drug Sample Collection for Analysis
Ban: Hookah Serving to be a Punishable Offense in Haryana
FOPE: Impact of revised Schedule M on Pharma and Nutraceuticals
IPC issues Draft Pharmacovigilance Guidance Document for Pharmaceuticals
Behind the Scenes: Decoding Leadership in India’s API Industry
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
